- Business
- Euroafrica Digital Ventures AB (publ) (EURA.ST), now operating as Deversify Health AB following a reverse acquisition by Deversify AB completed on August 1, 2024, develops and commercializes health technology solutions focused on metabolic health monitoring and education; its main products include Acetrack, a mobile electronic ketone breathalyzer that measures ketosis levels for consumers, businesses, and healthcare providers, and Elitista, a digital health education platform offering personalized coaching and tools for metabolic health improvement. The company, founded in 2016 as Deversify and headquartered in Uppsala, Sweden, targets global consumer markets (B2C) through direct e-commerce sites like getacetrack.com and elitista.se, as well as B2B2C channels via partnerships, resellers, and distributors in Europe, the United States, Canada, Australia, New Zealand, South Korea, and other regions. Previously a digital media technology firm with SaaS platforms for media planning, campaign optimization, publishing, and performance monitoring, along with operations in Tanzania's online marketplace Kupatana, the company underwent a major strategic shift in 2024, including the divestment of legacy subsidiaries such as Kupatana AB, Social Content AB, and Afrieuro Digital Ventures Ltd., a name change effective August 2, 2024, a ticker symbol update to DEV, conditional Nasdaq First North Growth Market listing approval, and a rights issue of units raising approximately SEK 43.8 million before costs to fund debt repayment, working capital, marketing, business development, and product expansion.